Pages that link to "Q35084110"
Jump to navigation
Jump to search
The following pages link to Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease (Q35084110):
Displaying 50 items.
- The generation and function of soluble apoE receptors in the CNS (Q21202840) (← links)
- Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease (Q21562116) (← links)
- Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease (Q22248091) (← links)
- Alzheimer's disease as homeostatic responses to age-related myelin breakdown (Q22251261) (← links)
- Alzheimer mechanisms and therapeutic strategies (Q22252311) (← links)
- Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation (Q24291128) (← links)
- CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P/collagen type XXV (Q24292980) (← links)
- Mostly separate distributions of CLAC- versus Abeta40- or thioflavin S-reactivities in senile plaques reveal two distinct subpopulations of beta-amyloid deposits (Q24297568) (← links)
- Association of apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer's disease brain (Q24302165) (← links)
- Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain (Q24308258) (← links)
- CLAC binds to amyloid beta peptides through the positively charged amino acid cluster within the collagenous domain 1 and inhibits formation of amyloid fibrils (Q24328940) (← links)
- Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. (Q24536203) (← links)
- Impact of apolipoprotein E on Alzheimer's disease (Q24567759) (← links)
- Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy (Q24604376) (← links)
- ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling (Q24616113) (← links)
- Enhancing CNS repair in neurological disease: challenges arising from neurodegeneration and rewiring of the network (Q24630696) (← links)
- Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1 (Q24672149) (← links)
- Similar promotion of Abeta1-42 fibrillogenesis by native apolipoprotein E epsilon3 and epsilon4 isoforms (Q24805441) (← links)
- With mouse age comes wisdom: A review and suggestions of relevant mouse models for age-related conditions (Q26741931) (← links)
- The amyloid hypothesis of Alzheimer's disease at 25 years (Q26749528) (← links)
- Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1 (Q26800063) (← links)
- Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's disease (Q26822534) (← links)
- Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease (Q26858870) (← links)
- Towards understanding the roles of heparan sulfate proteoglycans in Alzheimer's disease (Q26992202) (← links)
- Oxidized cholesterol as the driving force behind the development of Alzheimer's disease (Q27023315) (← links)
- HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer's disease. (Q27315985) (← links)
- HSV-1 and Alzheimer's disease: more than a hypothesis. (Q27692651) (← links)
- Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer's disease? (Q28069073) (← links)
- Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies? (Q28070156) (← links)
- ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease (Q28081654) (← links)
- Stem cell therapy for Alzheimer's disease and related disorders: current status and future perspectives (Q28085612) (← links)
- Alzheimer's disease: the cholesterol connection (Q28186482) (← links)
- Changes in Apolipoprotein E Expression in Response to Dietary and Pharmacological Modulation of Cholesterol (Q28204071) (← links)
- Structural basis for the recognition and cross-linking of amyloid fibrils by human apolipoprotein E (Q28252183) (← links)
- Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease (Q28265290) (← links)
- The pathogenic implication of abnormal interaction between apolipoprotein E isoforms, amyloid-beta peptides, and sulfatides in Alzheimer's disease (Q28269481) (← links)
- Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors (Q28394967) (← links)
- Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology (Q28504643) (← links)
- ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis (Q28504715) (← links)
- Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease (Q28504767) (← links)
- Identification of a Chrysanthemic Ester as an Apolipoprotein E Inducer in Astrocytes (Q28553918) (← links)
- In vivo human apolipoprotein E isoform fractional turnover rates in the CNS (Q28728902) (← links)
- Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells (Q28771380) (← links)
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics (Q29614972) (← links)
- Alzheimer's disease (Q29616743) (← links)
- The binding of apolipoprotein E to oligomers and fibrils of amyloid-β alters the kinetics of amyloid aggregation (Q30032680) (← links)
- PET amyloid-beta imaging in preclinical Alzheimer's disease (Q30040695) (← links)
- The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer's Disease Cohorts (Q30248596) (← links)
- Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance (Q30274556) (← links)
- Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress (Q30419992) (← links)